Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Ntsekhe, Mpiko ^a   Matthews, Kerryn ^b   Syed, Faisal F ^a,c   Deffur, Armin ^b   Badri, Motasim ^a,f   Commerford, Patrick J ^a   Gersh, Bernard J ^c   Wilkinson, Katalin A ^b,d   Wilkinson, Robert J ^b,d,e   Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MAYO CLINIC   (United States)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONSTRICTIVE PERICARDITIS; EFFUSIVE CONSTRICTIVE PERICARDITIS; FEMALE; HEART ATRIUM PRESSURE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIOCENTESIS; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TUBERCULOUS PERICARDITIS;

ADULT; AFRICA; CYTOKINES; FEMALE; HEMODYNAMICS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PERICARDIAL EFFUSION; PERICARDITIS, CONSTRICTIVE; PREVALENCE; TUBERCULOSIS;

EID: 84885403635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077532     Document Type: Article

References (29)

1. Sagristà-Sauleda J, Angel J, Sánchez A, Permanyer-Miralda G, Soler-Soler J, (2004) Effusive-Constrictive Pericarditis. N Engl J Med 350: 469-475. doi:10.1056/NEJMoa035630. PubMed: 14749455.
2. Hancock EW, (1971) Subacute Effusive-Constrictive Pericarditis. Circulation 43: 183-192. doi:10.1161/01.CIR.43.2.183. PubMed: 5540704.
3. Hancock EW, (2004) A clearer view of effusive-constrictive pericarditis. N Engl J Med 350: 435-437. doi:10.1056/NEJMp038199. PubMed: 14749449.
4. Sagristà-Sauleda J, (2004) Pericardial constriction: uncommon patterns. Heart 90: 257-258. doi:10.1136/hrt.2003.024828. PubMed: 14966039.
5. Salami MA, Adeoye PO, Adegboye VO, Adebo OA, (2012) Presentation pattern and management of effusive-constrictive pericarditis in Ibadan. Cardiovasc J Afr 23: 206-211. doi:10.5830/CVJA-2011-066. PubMed: 22614665.
6. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, et al. (2006) Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis 6: 2. doi:10.1186/1471-2334-6-2. PubMed: 16396690.
7. Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, et al. (2008) Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 98: 36-40. PubMed: 18270639.
8. Ntsekhe M, Wiysonge CS, Commerford PJ, Mayosi BM, (2012) The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature. Cardiovasc J Afr 23: 281-285. doi:10.5830/CVJA-2011-072. PubMed: 22240903.
9. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis J Pathol 214: 199-210. doi:10.1002/path.2277. PubMed: 18161745.
10. Syed FF, Mayosi BM, (2007) A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 50: 218-236. doi:10.1016/j.pcad.2007.03.002. PubMed: 17976506.
11. Shabetai R, (2004) Pericardial effusion: haemodynamic spectrum. Heart 90: 255-256. doi:10.1136/hrt.2003.024810. PubMed: 14966038.
12. Matthews K, Wilkinson KA, Kalsdorf B, Roberts T, Diacon A, et al. (2011) Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis. Tuberculosis (Edinb, Scotland) 91: 587-593. doi:10.1016/j.tube.2011.06.009. PubMed: 21767990.
13. Köksal D, Unsal E, Poyraz B, Kaya A, Savaş H, et al. (2006) The value of serum interferon-gamma level in the differential diagnosis of active and inactive pulmonary tuberculosis. Tuberk Toraks 54: 17-21. PubMed: 16615013.
14. Fiorenza G, Rateni L, Farroni MA, Bogué C, Dlugovitzky DG, (2005) TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett 98: 45-48. doi:10.1016/j.imlet.2004.09.008. PubMed: 15790507.
15. Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF, (2002) Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 6: 439-446. PubMed: 12019920.
16. Reuter H, Burgess LJ, Carstens ME, Doubell AF, (2005) Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb), 86(2005) Dec 14. PubMed: 16360340.
17. Reuter H, Burgess LJ, Louw VJ, Doubell AF, (2007) The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr 18: 20-25. PubMed: 17392991.
18. Redford PS, Murray PJ, O'Garra A, (2011) The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 4: 261-270. doi:10.1038/mi.2011.7. PubMed: 21451501.
19. Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, et al. (2008) HIV Infection Is Associated with a Lower Incidence of Constriction in Presumed Tuberculous Pericarditis: A Prospective Observational Study. PLOS ONE 3: e2253. doi:10.1371/journal.pone.0002253. PubMed: 18523576.
20. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254. doi:10.1084/jem.178.6.2249. PubMed: 7504064.
21. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, et al. (1993) Disseminated tuberculosis in Interferon-gamma gene-disrupted mice. J Exp Med 178: 2243-2247. doi:10.1084/jem.178.6.2243. PubMed: 8245795.
22. Sasse SA, Jadus MR, Kukes GD, (2003) Pleural Fluid Transforming Growth Factor beta Correlates with Pleural Fibrosis in Experimental Empyema. Am J Respir Crit Care Med 168: 700-705. doi:10.1164/rccm.2202043. PubMed: 12963580.
23. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, et al. (2003) Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGFbeta and IL-10. Eur Respir J 22: 69-76. doi:10.1183/09031936.03.00014703. PubMed: 12882453.
24. Barbarin V, Xing Z, Delos M, Lison D, Huaux F, (2005) Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 288: L841-L848. doi:10.1152/ajplung.00329.2004. PubMed: 15608148.
25. Seiscento M, Vargas FS, Antonangelo L, Acencio MMP, Bombarda S, et al. (2007) Transforming growth factor β-1 as a predictor of fibrosis in tuberculous pleurisy. Respirology 12: 660-663. doi:10.1111/j.1440-1843.2007.01135.x. PubMed: 17875052.
26. Jöbsis PD, Ashikaga H, Wen H, Rothstein EC, Horvath KA, et al. (2007) The visceral pericardium: macromolecular structure and contribution to passive mechanical properties of the left ventricle. Am J Physiol Heart Circ Physiol 293: H3379-H3387. doi:10.1152/ajpheart.00967.2007. PubMed: 17933976.
27. Hernandez-Pando R, Rook GA, (1994) The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 82: 591-595. PubMed: 7835922.
28. Mayosi BM, (2007) Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 93: 1176-1183. doi:10.1136/hrt.2007.127746. PubMed: 17890693.
29. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, et al. (2004) Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 25: 587-610. doi:10.1016/j.ehj.2004.02.002. PubMed: 15120056.